FBI: Feeling and Body Investigators

Sponsor
Duke University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02075437
Collaborator
(none)
126
2
1
78.1
63
0.8

Study Details

Study Description

Brief Summary

This study will provide tools to develop and pilot an intervention for Functional Abdominal Pain (FAP) using a ten session intervention with children ages 5-8. Investigators will train the subjects to be "Feeling and Body Investigators". During treatment phases the following will occur 1) gather clues (learn), 2) investigate (experience: perform interoceptive mystery missions to explore a body sensation), 3) organize body clues (contextualize: recall other contexts that evoke similar sensations), and 4) go on increasingly daring missions (challenge: decrease avoidance and safety behaviors). The FBI intervention will be developed and refined in 26 child-caregiver dyads during the current R21 phase. In the R33 phase investigators will randomize 100 subjects with FAP to FBI or an active control group in order to conduct a pilot-test of the feasibility, acceptance, and clinical significance of FBI. Young children with FAP who complete the FBI early intervention will learn to experience changes in the viscera as fun and fascinating, rather than scary, and will develop new capacities for pain management, adaptive functioning, and emotion regulation. For the R21 Phase (assessing initial feasibility) investigators hypothesize that ≥ 80% of participants enrolled in FBI will complete treatment and that ≥ 80% of participants will complete home-based practice assignments.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Feeling and Body Investigators with Functional Abdominal Pain
  • Behavioral: Treatment Strategies
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
126 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Feelings and Body Investigators (FBI): Interoceptive Exposure for Child Abdominal Pain
Actual Study Start Date :
Mar 1, 2014
Anticipated Primary Completion Date :
Sep 1, 2020
Anticipated Study Completion Date :
Sep 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Functional Abdominal Pain (FAP)

To access (FAP) subjects will participate in: 10 therapy sessions; and the following treatments: 1) identify strategies with unique patterns of neural circuit maturation associated with early visceral pain on the gut-brain axis: 2) adapt acceptance-based behavioral strategies used to address psychopathology in older children to younger children; and 3) incorporate caregivers as role models and facilitators based on attachment research.

Behavioral: Feeling and Body Investigators with Functional Abdominal Pain
Investigator's ten session intervention trains children to be "Feeling and Body Investigators". Half of the sessions will be done in clinic and half at home via web-camera to facilitate generalization. During the treatment child/caregiver dyads will 1) gather body clues (Learn), 2) investigate (Experience: perform interoceptive mystery missions to explore a body sensation), 3) organize body clues (Contextualize: recall other context that evoke similar sensations), and 4) go on increasingly daring missions (Challenge: decrease avoidance and safety behaviors). If successful, young children with FAP who complete the FBI early intervention will learn to experience changes in the viscera as fun and fascinating, rather than scary, and will develop new capacities for pain management, adaptive functioning, and emotion regulation.
Other Names:
  • Ten Session Therapy for Young Children with Functional Abdominal Pain
  • Behavioral: Treatment Strategies
    identify strategies with unique patterns of neural circuit maturation associated with early visceral pain on the gut-brain axis: adapt acceptance-based behavioral strategies used to address psychopathology in older children to younger children; incorporate caregivers as role models and facilitators based on attachment research.

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of Participants Who Complete Treatment [1.5 Years]

      Treatment in this study refers to10 treatment sessions (4 via webcam or over cell phone video chat from the subject's home and 6 in the investigator's lab) using an acceptance-based behavioral treatment for children 5 through 8 years old with impairing functional abdominal pain. This intervention is rooted in a biopsychosocial framework incorporating advances in neurodevelopment, behavioral learning theory, and attachment theory.

    2. Percentage of Participants Completing Homework Assignment [1.5 Years]

      Enrollees will engage in assigned home-based practice sessions for at least nine of the ten treatment weeks. Completion of assigned practice sessions within a given week is defined as success.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Months to 107 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Child is between 60 and 107 months old.

    • Parent/legal guardian is present at the clinic visit who speaks English

    • Child screens positive for recurrent abdominal pain by having: 1) 8 episodes of abdominal pain over 2 months (based on Rome III criteria), or 2) 2 or more episodes of abdominal pain which are causing an incapacity greater than or equal to 25% of the time in the past two months).

    • Based on pediatric medical assessment, child meets criteria for functional abdominal pain (FAP) based on absence of other organic causes of recurrent abdominal pain.

    • Consent given by caregiver and assent by child to participate.

    • Presence of internet access, including that accessed by cell phone with video capabilities.

    Exclusion Criteria:
    • The index child being known to have mental retardation (IQ < 70) or other pervasive developmental disorders.

    • Subject has a sibling who is already enrolled in our study. Possible Exclusion

    • Parent/ guardian who would be participating in the study is pregnant.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Duke University Young Child Lab at Brightleaf Square Durham North Carolina United States 27701
    2 Duke Children's Primary Care Picket Road Durham North Carolina United States 27705

    Sponsors and Collaborators

    • Duke University

    Investigators

    • Principal Investigator: Nancy Zucker, PhD, Director, Duke Center for Eating Disorders, Assistant Professor
    • Principal Investigator: Helen Egger, MD, Head, Division of Child and Adolescent Psychiatry, Associate Professor

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Duke University
    ClinicalTrials.gov Identifier:
    NCT02075437
    Other Study ID Numbers:
    • Pro00043556
    • MH097959
    First Posted:
    Mar 3, 2014
    Last Update Posted:
    Aug 26, 2020
    Last Verified:
    Aug 1, 2020
    Keywords provided by Duke University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 26, 2020